#oralpresentation — Public Fediverse posts

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

ZENTALIS PHARMACEUTICALS SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator…
#Europe #EU #clinicaltrial #Cyclin #DENALI #enrolledpatients #European #Inc. #oralpresentation #ovariancancer #PROC #QD #Zentalis®Pharmaceuticals
https://www.europesays.com/europe/97024/

https://www.europesays.com/dk/116967/ Novo Nordisk to showcase new data across its hemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig #Hemophilia #HemophiliaA #inhibitors #NovoNordisk #OralPresentation #PosterPresentation #prophylaxis #RareBloodDisorders

https://www.europesays.com/ch/78662/ Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases #AutoimmuneDiseases #DataPrivacy #EULAR #Immunology #Novartis #OralPresentation #PolymyalgiaRheumatica #ShapingTheFuture #SystemicLupusErythematosus #SystemicSclerosis

https://www.europesays.com/ch/77286/ Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases #AutoimmuneDiseases #DataPrivacy #EULAR #Immunology #Novartis #OralPresentation #PolymyalgiaRheumatica #ShapingTheFuture #SystemicLupusErythematosus #SystemicSclerosis

https://www.europesays.com/ch/76693/ Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026 #AAD #ChronicDiseases #ChronicSpontaneousUrticaria #Cosentyx #DataIntegrity #DataPrivacy #EfficacyData #HidradenitisSuppurativa #Novartis #OralPresentation

https://www.europesays.com/ch/76635/ New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength #DataIntegration #DataPrivacy #EuropeanRenalAssociation #IgANephropathy #KidneyCare #KidneyDiseases #KidneyFunction #Novartis #OralPresentation #patients

https://www.europesays.com/ch/75446/ Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases #AutoimmuneDiseases #DataPrivacy #EULAR #Immunology #Novartis #OralPresentation #PolymyalgiaRheumatica #ShapingTheFuture #SystemicLupusErythematosus #SystemicSclerosis

https://www.europesays.com/ch/75434/ Novartis announces results on rPFS improvements across subgroups with Pluvicto #AmericanSocietyOfClinicalOncology #DiseasePresentation #Novartis #OralPresentation #Pluvicto #ProstateCancer #RadiographicProgression

https://www.europesays.com/ch/72749/ New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength #DataIntegration #DataPrivacy #EuropeanRenalAssociation #IgANephropathy #KidneyCare #KidneyDiseases #KidneyFunction #Novartis #OralPresentation #patients

https://www.europesays.com/ch/71911/ New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength #DataIntegration #DataPrivacy #EuropeanRenalAssociation #IgANephropathy #KidneyCare #KidneyDiseases #KidneyFunction #Novartis #OralPresentation #patients

https://www.europesays.com/dk/79381/ Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity #NovoNordisk #Obesity #OralPresentation #PostHocAnalysis #PosterSession #presentation #Wegovy

https://www.europesays.com/dk/70244/ Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity #NovoNordisk #Obesity #OralPresentation #PostHocAnalysis #PosterSession #presentation #Wegovy

https://www.europesays.com/people/2437/ Inside Supreme Court: How Trump heard birthright citizenship arguments #BirthrightCitizenship #ChiefJusticeJohnRoberts #citizenship #JohnRoberts #OralArguments #OralPresentation #PresidentDonaldTrump #SupremeCourt

https://www.europesays.com/ch/36921/ Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026 #AAD #ChronicDiseases #ChronicSpontaneousUrticaria #Cosentyx #DataIntegrity #DataPrivacy #EfficacyData #HidradenitisSuppurativa #Novartis #OralPresentation